Schizophrenia trials recruiting in New Jersey
All Schizophrenia trials nationally
18
Recruiting in New Jersey
7
Cities with sites
Cities in New Jersey
Marlton 11Toms River 2Belle Mead 1Neptune City 1Paramus 1Piscataway 1West Long Branch 1
Recruiting trials in New Jersey
- A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- A Study to Evaluate the Effect of KarXT on Urological Safety
- A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
- A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Randomized Withdrawal Study in Patients With Schizophrenia
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder